Related Experiment Video
Updated: Dec 25, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of
Sining Shen1, Ke Li2, Ying Liu2
1Department of Thoracic Surgery, Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou 450008, P.R. China.
Abstract:
The interaction of long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and mRNAs has been implicated in various types of cancers, including esophageal cancer (EC). The current study aimed to investigate the role of AGAP2-AS1/miR-195-5p/Fos-like antigen-1 (FOSL1) in EC progression. The expression of AGAP2-AS1, miR-195-5p, and FOSL1 in tumor tissues isolated from EC patients and EC cell lines was determined by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), the results of which illustrated that AGAP2-AS1 and FOSL1 were increased while miR-195-5p was reduced in EC. Next, the ectopic expression, knockdown, and reporter assay experiments were all employed to elucidate the mechanism of AGAP2-AS1/miR-195-5p/FOSL1 in the processes of EC cell proliferation, cell cycle, apoptosis, invasion, and migration as well as tumor growth. Knockdown of AGAP2-AS1 or overexpression of miR-195-5p reduced EC cell proliferation, migration, and invasion, blocked cell cycle entry, and elevated apoptosis. FOSL1 was found to be specifically targeted by miR-195-5p. AGAP2-AS1 was observed to upregulate FOSL1 by binding to miR-195-5p. Silencing of AGAP2-AS1 was observed to restrain the development of EC both in vitro and in vivo through upregulating miR-195-5p and downregulating FOSL1. Taken together, AGAP2-AS1 knockdown exercises suppressive effects on the development of EC through miR-195-5p-dependent downregulation of FOSL1. Therefore, targeting AGAP2-AS1 could be a future direction to develop a novel molecule-targeted therapeutic strategy for EC.
Insights
Targeting AGAP2-AS1, a long non-coding RNA, can suppress esophageal cancer (EC) progression. This involves upregulating miR-195-5p and downregulating FOSL1, offering a potential new therapeutic strategy for EC.
Area of Science:
- Molecular Oncology
- Cancer Biology
- RNA Biology
Background:
- Long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) interactions are crucial in cancer development.
- Esophageal cancer (EC) progression is influenced by complex molecular pathways.
- Understanding the specific roles of lncRNA/miRNA/mRNA axes is vital for targeted therapies.
Purpose of the Study:
- To investigate the role of the AGAP2-AS1/miR-195-5p/FOSL1 axis in esophageal cancer (EC) progression.
- To elucidate the molecular mechanisms underlying EC development involving these key molecules.
- To evaluate the therapeutic potential of targeting this axis in EC.
Main Methods:
- Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to determine expression levels of AGAP2-AS1, miR-195-5p, and FOSL1.
- In vitro experiments including ectopic expression, knockdown, and reporter assays to study cellular processes.
- In vivo studies to assess the effect of AGAP2-AS1 silencing on tumor growth.
Main Results:
- AGAP2-AS1 and FOSL1 were upregulated, while miR-195-5p was downregulated in EC tissues and cell lines.
- AGAP2-AS1 knockdown or miR-195-5p overexpression inhibited EC cell proliferation, migration, and invasion, and promoted apoptosis.
- miR-195-5p directly targets FOSL1, and AGAP2-AS1 upregulates FOSL1 by sponging miR-195-5p.
Conclusions:
- AGAP2-AS1 promotes EC development by upregulating FOSL1 via sponging miR-195-5p.
- Silencing AGAP2-AS1 restrains EC progression both in vitro and in vivo.
- Targeting AGAP2-AS1 represents a promising therapeutic strategy for esophageal cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
lncRNA - Long Non-coding RNAs
Cancer Cell Migration through Invadopodia
Cell Migration